Aemetis (NASDAQ:AMTX) Price Target Raised to $19.00

Aemetis (NASDAQ:AMTX) had its price objective raised by Ascendiant Capital Markets from $18.00 to $19.00 in a research note published on Monday morning,Benzinga reports. The firm currently has a buy rating on the specialty chemicals company’s stock.

Other research analysts have also issued reports about the stock. StockNews.com upgraded shares of Aemetis to a “sell” rating in a research note on Wednesday, February 5th. HC Wainwright reiterated a “buy” rating and issued a $28.00 price target on shares of Aemetis in a research note on Friday, March 14th. One analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Aemetis presently has an average rating of “Hold” and a consensus target price of $14.56.

Aemetis Price Performance

Shares of Aemetis stock opened at $2.00 on Monday. The company has a 50-day moving average of $2.12 and a 200 day moving average of $2.66. The firm has a market cap of $102.31 million, a price-to-earnings ratio of -0.88 and a beta of 1.48. Aemetis has a 1 year low of $1.50 and a 1 year high of $7.03.

Institutional Trading of Aemetis

Institutional investors and hedge funds have recently bought and sold shares of the company. ProShare Advisors LLC bought a new stake in Aemetis during the 4th quarter valued at about $27,000. Tower Research Capital LLC TRC increased its stake in Aemetis by 128.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 10,407 shares of the specialty chemicals company’s stock valued at $28,000 after purchasing an additional 5,859 shares in the last quarter. Voya Investment Management LLC bought a new stake in Aemetis during the 4th quarter valued at about $28,000. Clear Harbor Asset Management LLC purchased a new stake in shares of Aemetis during the 4th quarter valued at about $44,000. Finally, Intech Investment Management LLC purchased a new stake in shares of Aemetis during the 4th quarter valued at about $46,000. 27.02% of the stock is currently owned by institutional investors.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.